|
 Information
 Merz - our research for your health. Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist.
Information: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Information is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Information now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Information very serious, so that we can offer you the best drug for each treatment and therapy you need. Information and Merz means research for your health. High-quality products and information about Information can be found on our website. Visit us online and learn everything about Information from one of Germany's leading health care companies. Our contribution to Information: read here what we can do for you. Further links: Axura: Information for professionals.>>>
Information: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . The pathological, sustained release of low glutamate concentrations, from both neurones and surrounding glia cells, also displaces magnesium from the NMDA receptor channel. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . Therefore memantine has a low potential for day-day interactions in these multimorbid patients. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . The pathological, sustained release of low glutamate concentrations, from both neurones and surrounding glia cells, also displaces magnesium from the NMDA receptor channel. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . A significant improvement in cognitive performance is seen during treatment with the NMDA antagonist, especially when only small vessels are affected. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Calcium enters into the cell, and through secondary processes, the signal is recognized. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . Dysfunction of glutamatergic neurotransmission is involved in pathomechanism of neurodegenerative dementia. In the case of learning and memory processes, the transient synaptic release of glutamate causes more calcium to flow into the cell. During learning and memory processes (i e transient high glutamate release), memantine - the fast, voltage-dependent NMDA-receptor antagonist - leaves the NMDA receptor for a short time. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . Recent results from a Phase III trial show that patients receiving a combination of memantine and donepezil performed significantly better than patients receiving donepezil and placebo. NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . A significant improvement in cognitive performance is seen during treatment with the NMDA antagonist, especially when only small vessels are affected. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Gedächtnis , Demenz . Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . The intracellular calcium pool is reduced, and the noise lower. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . The 2 large studies have shown positive effects of memantine in mild to moderate cases of vascular dementia. Under physiological conditions, the NMDA receptor is blocked by magnesium ions, thereby protecting the neuron against glutamatergic excitotoxicity. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . The pathological, sustained release of low glutamate concentrations, from both neurones and surrounding glia cells, also displaces magnesium from the NMDA receptor channel. There is a continuous influx of calcium into the cell, increasing the calcium pool. The intracellular calcium pool is reduced, and the noise lower. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Information
|
